NCT04234464View on ClinicalTrials.gov

A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 15, 2020

Primary Completion Date

August 28, 2020

Study Completion Date

August 28, 2020

Conditions
Exercise Induced Bronchospasm
Interventions
COMBINATION_PRODUCT

Budesonide/albuterol sulfate metered-dose inhaler 160/180 μg

Budesonide/albuterol sulfate combination inhalation aerosol single dose

COMBINATION_PRODUCT

Placebo metered-dose inhaler

Placebo inhalation aerosol single dose

Trial Locations (6)

22015

Research Site, Burke

27607

Research Site, Raleigh

63109

Research Site, St Louis

80230

Research Site, Denver

02747

Research Site, North Dartmouth

08558

Research Site, Skillman

All Listed Sponsors
lead

Bond Avillion 2 Development LP

INDUSTRY

NCT04234464 - A Study to Assess the Efficacy of Budesonide/Albuterol Metered-dose Inhaler (BDA MDI/PT027) on Exercise-induced Bronchoconstriction in Adults and Adolescents With Asthma | Biotech Hunter | Biotech Hunter